Pfizer Pharmacokinetics Study PF-07328948 in Healthy Male Adults
Summary
The National Library of Medicine registered Pfizer Study NCT07508228 on ClinicalTrials.gov, a Phase 1 pharmacokinetics trial evaluating PF-07328948 in healthy male adults. The study is listed with standard enrollment parameters and investigator information for public disclosure.
What changed
Pfizer registered a new Phase 1 clinical trial (NCT07508228) on ClinicalTrials.gov testing PF-07328948 for pharmacokinetic assessment in healthy male adults. The registration includes standard protocol details such as eligibility criteria, study design, and participating investigators.\n\nPharmaceutical companies and clinical investigators conducting similar pharmacokinetic studies should ensure their trials are properly registered on ClinicalTrials.gov per FDAAA 801 requirements. Patients seeking enrollment in Phase 1 studies may reference this listing for eligibility assessment.
Archived snapshot
Apr 3, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NLM.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.